| Next Generation NP-Paclitaxel | LM-101; Nanoparticle Paclitaxel; Metastatic Breast Cancer, Ovarian, Pancreatic, NSCLC |
| Personalized Dosing NP-Paclitaxel | LM-201; Personalized paclitaxel (LM-101) via TDM (Therapeutic Drug Monitoring) device |
| Biomarker-based Personalized Dosing NP-Paclitaxel | LM-301; Personalized paclitaxel (LM-101) via TDM + biomarker-based patient selection for ovarian cancer |
